Intrinsic value of Neumora Therapeutics, Inc. Common Stock (NMRA)
Live fair value data for Neumora Therapeutics, Inc. Common Stock (NMRA) is currently unavailable. Please check again shortly.
Current Price: $42.00
Valuation: Undervalued
Confidence: 5.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Neumora Therapeutics, Inc. Common Stock (NMRA) undervalued or overvalued?
Based on the current model output, Neumora Therapeutics, Inc. Common Stock appears to be undervalued with a upside of 10.00%.
Fair value vs market price — Neumora Therapeutics, Inc. Common Stock (NMRA)
Unlock premium access to view the live fair value comparison against current market price for NMRA.
Frequently Asked Questions - NMRA
How is NMRA intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for NMRA.
Is NMRA undervalued or overvalued right now?
NMRA is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for NMRA: open their intrinsic value pages.